Dopamine-antagonistic, anticholinergic, and GABAergic effects on declarative and procedural memory functions

Cognitive Brain Research

Volumn 9, Issue 1, 2000, Pages 61-71

  Rammsayer, Thomas H ^a   Rodewald, Steffen ^a   Groh, Denise ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Acetylcholine; Declarative memory; Dopamine; Procedural memory; Aminobutyric acid

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; DOPAMINE; HALOPERIDOL; MIDAZOLAM; PLACEBO; SCOPOLAMINE;

ADULT; ANTICHOLINERGIC EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DOPAMINERGIC SYSTEM; DOUBLE BLIND PROCEDURE; GABAERGIC SYSTEM; HUMAN; HUMAN EXPERIMENT; LEARNING; MALE; MEMORY; MOTOR PERFORMANCE; NEUROPSYCHOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; RECOGNITION; RESPONSE TIME; REVIEW; WORD RECOGNITION;

EID: 0033957288     PISSN: 09266410     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-6410(99)00045-2     Document Type: Article

References (87)

1. [1] A. Abi-Dargham, R. Gil, J. Krystal, R.M. Baldwin, J.P. Seibyl, M. Bowers, C.H. van Dyck, D.S. Charney, R.B. Innis, M. Laruelle, Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort, American Journal of Psychiatry 155 (1998) 761-767.
2. [2] T. Ali-Melkkilä, J. Kanto, E. Iisalo, Pharmacokinetics and related pharmacodynamics of anticholinergic drugs, Acta Anaesthesiologica Scandinavica 37 (1993) 633-642.
3. [3] H. Allain, A. Lieury, V. Thomas, J.M. Reymann, J.M. Gandon, S. Belliard, Explicit and procedural memory in Parkinson's disease, Biomedicme and Pharmacotherapy 49 (1995) 179-186.
4. [4] T. Allison, H. Ginter, G. McCarthy, A.C. Nobre, A. Puce, M. Luby, D.D. Spencer, Face recognition in human extrastriate cortex, Journal of Neurophysiology 71 (1994) 821-825.
5. [5] N.C. Andreasen, Brain imaging: applications in psychiatry, Science 239 (1988) 1381-1388.
6. [6] N.C. Andreasen, D.S. O'Leary, S. Arndt, T. Cizadlo, R. Hurtig, K. Rezai, G.L. Watkins, L. Boles Ponto, R.D. Hichwa, Neural substrates of facial recognition, Journal of Neuropsychiatry 8 (1996) 139-146.
7. [7] J. Archer, D.C. Hay, A.W. Young, Face processing in psychiatric conditions, British Journal of Clinical Psychology 31 (1992) 45-61.
8. [8] R.C. Atkinson, R.M. Shiffrin, Human memory: a proposed system and its control processes, in: K.W. Spence (Ed.), The Psychology of Learning and Motivation: Advances in Research and Theory, Vol. 2, Academic Press, New York, 1968, pp. 89-195.
9. [9] A.D. Baddeley, The Psychology of Memory. Harper & Row, New York, 1976.
10. [10] R.T. Baschek, J. Bredenkamp, B. Oehrle, W. Wippich, Determination of imagery, concreteness, and meaningfulness of 800 nouns, Zeitschrift für Experimentelle und Angewandte Psychologie 24 (1977) 353-396.
11. [11] R. Bertorelli, M. Zambelli, G. Di Chiara, S. Consolo, Dopamine depletion preferentially impairs D1-over D2-receptor regulation of striatal in vivo acetylcholine release, Journal of Neurochemistry 59 (1992) 353-357.
12. [12] A. Björklund, O. Lindvall, Catecholaminergic brain stem regulatory systems, in: American Physiological Society (Ed.), Handbook of Physiology. Section 1: The Nervous System, Vol. IV, Intrinsic Regulatory Systems of the Brain, American Physiological Society, Bethesda, MD, 1986, pp. 155-235.
13. [13] A. Blokland, Acetylcholine: a neurotransmitter for learning and memory?, Brain Research Reviews 21 (1996) 285-300.
14. [14] L.D. Bornemann, B.H. Min, T. Crews, M.M.C. Rees, H.P. Blumenthal, W.A. Colburn, J.H. Patel, Dose dependent pharmacokinetics of midazolam, European Journal of Clinical Pharmacology 32 (1985) 91-95.
15. [15] M.W. Brown, J. Brown, J. Bowes, Absence of priming coupled with substantially preserved recognition in lorazepam induced amnesia, Quarterly Journal of Experimental Psychology 41A (1989) 599-617.
16. [16] A. Carlsson, The current status of the dopamine hypothesis of schizophrenia, Neuropsychopharmacology 1 (1988) 179-186.
17. [17] A. Carlsson, Antipsychotic drugs, neurotransmitters and schizophrenia, American Journal of Psychiatry 135 (1978) 164-173.
18. [18] H. Christensen, N. Maltby, A.F. Jorm, H. Creasy, G.A. Broe, Cholinergic "blockade" as a model of the cognitive deficits in Alzheimer's disease, Brain 115 (1992) 1681-1699.
19. [19] H.V. Curran, B. Birch, Differentiating the sedative, psychomotor and amnesic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil, Psychopharmacology 103 (1991) 519-523.
20. [20] H.V. Curran, P. Pooviboonsuk, J.A. Dalton, M.H. Lader, Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine, Psychopharmacology 135 (1998) 27-36.
21. [21] J.M. Danion, M.-A. Zimmermann, D. Willard-Schroeder, D. Grange, L. Singer, Diazepam induces a dissociation between explicit and implicit memory, Psychopharmacology 99 (1989) 238-243.
22. [22] J.M. Danion, M.A. Zimmermann, D. Willard-Schroeder, D. Grange, M. Welsch, J.L. Imbs, L. Singer, Effects of scopolamine, trimipramine and diazepam on explicit memory and repetition priming in healthy volunteers, Psychopharmacology 102 (1990) 422-424.
23. [23] R. Dayne-Mayfield, G. Larson, R.A. Orona, N.R. Zahniser, Opposing actions of adenosine A2a and dopamine D2 receptor activation on GABA release in the basal ganglia: evidence for an A2a/D2 receptor interaction in the globus pallidus, Synapse 22 (1996) 132-138.
24. [24] R. Desimone, Face-selective cells in the temporal cortex of monkeys, Journal of Cognitive Neuroscience 3 (1991) 1-8.
25. [25] J.C. Fang, J.V. Hinrichs, M.M. Ghoneim, Diazepam and memory: evidence for spared memory function, Pharmacology Biochemistry and Behavior 28 (1987) 347-352.
26. [26] M.J. Farah, Is face recognition "special"? Evidence from neuropsychology, Behavioral Brain Research 76 (1996) 181-189.
27. [27] M.J. Farah, K.D. Wilson, M. Drain, J.N. Tanaka, What is "special" about face perception?, Psychological Review 105 (1998) 482-498.
28. [28] T.E. Feinberg, A. Rifkin, C. Schaffer, E. Walker, Facial discrimination and emotional recognition in schizophrenia and affective disorders, Archives of General Psychiatry 43 (1986) 276-279.
29. [29] H.C. Fibiger, Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence, Trends in Neurosciences 14 (1991) 220-223.
30. [30] S. File, Effects of lorazepam on psychomotor performance: a comparison of independent-groups and repeated-measures designs, Pharmacology Biochemistry and Behavior 42 (1992) 761-764.
31. [31] A.O. Forsman, Haloperidol: a new profile?, Proceedings of the Royal Society of Medicine 69 (1976) 9-13, Suppl. 1.
32. [32] C.D. Frith, C.A. Bloxham, K.N. Carpenter, Impairments in the learning and performance of a new manual skill in patients with Parkinson's disease, Journal of Neurology, Neurosurgery, and Psychiatry 49 (1986) 661-668.
33. [33] C.D. Frith, M.A. McGinty, I. Gergel, T.J. Crow, The effects of scopolamine and clonidine upon performance and learning of a motor skill, Psychopharmacology 98 (1989) 120-125.
34. [34] S. Gessler, J. Cutting, C.D. Frith, J. Weinman, Schizophrenic inability to judge facial emotion: a controlled study, British Journal of Clinical Psychology 28 (1989) 19-29.
35. [35] M.M. Ghoneim, S.P. Mewaldt, Benzodiazepines and human memory: a review, Anaesthesiology 72 (1990) 926-938.
36. [36] M.M. Ghoneim, R.I. Block, V.J. Dhanaraj, Interactions of a sub-anaesthetic concentration of isoflurane with midazolam: effects on responsiveness, learning and memory, British Journal of Anaesthesiology 80 (1998) 581-587.
37. [37] M.M. Ghoneim, R.I. Block, S.T. Ping, H.M. el Zahaby, J.V. Hinrichs, The interactions of midazolam and flumenazil on human memory and cognition, Anesthesiology 79 (1993) 1183-1192.
38. [38] D.M. Green, T.G. Birdsall, Detection and recognition, Psychological Review 85 (1978) 192-206.
39. [39] J.F. Green, A. McElholm, D.J. King, A comparison of the sedative and amnestic effects of chlorpromazine and lorazepam, Psychopharmacology 128 (1996) 67-73.
40. [40] L.G. Harsing, M.J. Zigmond, Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences, Neuroscience 77 (1997) 419-429.
41. [41] J.V. Haxby, C.L. Grady, B. Horwitz, J. Salerno, L.G. Ungerleider, M. Mishkin, M.B. Schapiro, Dissociation of object and spatial visual processing pathways in human extrastriate cortex, in: B. Gulyas, D. Ottoson, P.E. Roland (Eds.), Functional Organisation of the Human Visual Cortex, Pergamon, Oxford, 1993, pp. 329-340.
42. [42] K. Henke, S.R. Schweinberger, A. Grigo, T. Klos, W. Sommer, Specificity of face recognition: recognition of exemplars of non-face objects in propagnosia, Cortex 34 (1998) 289-296.
43. [43] M.J. Hennessy, K.C. Kirkby, I.M. Montgomery, Comparison of the amnesic effects of midazolam and diazepam, Psychopharmacology 103 (1991) 545-550.
44. [44] I. Hindmarch, Critical flicker fusion frequency (CFF): the effects of psychotropic compounds, Pharmacopsychiatry 15 (1982) 44-48, Suppl. 1.
45. [45] Y. Ikarashi, A. Takahashi, H. Ishimaru, T. Arai, Y. Maruyama, Regulation of dopamine D1 and D2 receptors on striatal acetylcholine release in rats, Brain Research Bulletin 43 (1997) 107-115.
46. [46] W. James, Principles of Psychology, Vol. 1, Holt, New York, 1890.
47. [47] H.R. Jex, J.D. McDonnell, A.V. Phatak, A "critical" tracking task for manual control research, IEEE Transactions on Human Factors in Electronics 7 (1966) 138-144.
48. [48] D.J. King, BAP consensus statement: guidelines for the use of antipsychotic drug studies in healthy volunteers, Journal of Psychopharmacology 11 (1997) 201-210.
49. [49] M.D. Kopelman, The cholinergic neurotransmitter system in human memory and dementia: a review, Quarterly Journal of Experimental Psychology 38A (1986) 535-573.
50. [50] M. Laruelle, A. Abi-Dargham, C.H. van Dyck, R. Gil, C.D. D'Souza, J. Erdos, E. McCance, W. Rosenblatt, C. Fingado, S.S. Zoghbi, R.M. Baldwin, J.P. Seibyl, J.H. Krystal, D.S. Charney, R.B. Innis, Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects, Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 9235-9240.
51. [51] S.C. Levine, The question of faces: special is in the brain of the beholder, in: A.W. Young, H.D. Ellis (Eds.), Handbook of Research on Face Processing, Elsevier, Amsterdam, 1989, pp. 37-48.
52. [52] R.G. Lister, The amnesic action of benzodiazepines in man, Neuroscience and Biobehavioral Reviews 9 (1985) 87-94.
53. [53] N.A. Macmillan, Creelman, C.D., Detection Theory: A User's Guide, Cambridge Univ. Press, Cambridge, 1991.
54. [54] M.-M. Mesulam, From sensation to cognition, Brain 121 (1998) 1013-1052.
55. [55] M. Mishkin, B. Malamut, J. Bachevalier, Memories and habits: two neural systems, in: G. Lynch, J.L. McGaugh, N.M. Weinberger (Eds.), Neurobiology of Learning and Memory, Guilford Press, New York, 1984, pp. 313-334.
56. [56] H. Möller, J.G. Richards, The benzodiazepine receptor: a pharmacological control element of brain function, European Journal of Anaesthesiology 2 (1988) 15-24, Suppl.
57. [57] C.A. Nelson, The ontogeny of human memory: a cognitive neuroscience perspective, Developmental Psychology 31 (1995) 723-738.
58. [58] M.J. Nissen, D.S. Knopman, D.L. Schacter, Neurochemical dissociation of memory systems, Neurology 37 (1987) 789-794.
59. [59] R. Öhman, A. Forsman, M. Larsson, Prolactin response to haloperidol after a single dose and during prolonged administration, Current Therapeutic Research 27 (1980) 137-143.
60. [60] S.J. Peroutka, S.H. Snyder, Relationship of neuroleptic drug effects at brain dopamine, serotonin, adrenergic and histamine receptors to clinical potency, American Journal of Psychiatry 137 (1980) 1518-1522.
61. [61] M.R. Polster, Drug-induced amnesia: implications for cognitive neuropsychological investigations of memory, Psychological Bulletin 114 (1993) 477-493.
62. [62] A.M. Poreh, R.D. Whitman, M. Weber, T. Ross, Facial recognition in hypothetically schizotypic college students, Journal of Nervous and Mental Disease 182 (1994) 503-507.
63. [63] A. Porras, F. Mora, Dopamine-glutamate-GABA interactions and ageing: studies in the striatum of conscious rat, European Journal of Neuroscience 7 (1995) 2183-2188.
64. A receptor subunit for benzodiazepine pharmacology, Nature 338 (1989) 582-585.
65. [65] T. Rammsayer, Effects of benzodiazepine-induced sedation on temporal processing, Human Psychopharmacology 7 (1992) 311-318.
66. [66] T.H. Rammsayer, Effects of body core temperature and brain dopamine activity on timing processes in humans, Biological Psychology 46 (1997) 169-192.
67. [67] T.H. Rammsayer, Extraversion and dopamine: individual differences in responsiveness to changes in dopaminergic activity as a possible biological basis of extraversion, European Psychologist 3 (1998) 37-50.
68. [68] T. Rammsayer, B. Gallhofer, Remoxipride versus haloperidol in healthy volunteers: psychometric performance and subjective tolerance profiles, International Clinical Psychopharmacology 10 (1995) 31-37.
69. [69] T.W. Robbins, J. Semple, R. Kumar, M.I. Truman, J. Shorter, A. Ferraro, B. Fox, G. McKay, K. Matthews, Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia, Psychopharmacology 134 (1997) 95-106.
70. [70] J.M. Rusted, D.M. Warburton, Cognitive models and cholinergic drugs, Neuropsychobiology 21 (1989) 31-36.
71. [71] J.A. Saint-Cyr, A.E. Taylor, A.E. Lang, Procedural learning and neostriatal dysfunction in man, Brain 111 (1988) 941-959.
72. [72] D.P. Salmon, N. Butters, Neurobiology of skill and habit learning, Current Opinions in Neurobiology 5 (1995) 184-190.
73. [73] D.L. Schacter, Implicit memory: history and current status, Journal of Experimental Psychology: Learning, Motivation and Cognition 13 (1987) 510-518.
74. [74] M. Seeck, O.-J. Grüsser, Category-related components in visual evoked potentials: photographs of faces, persons, flowers and tools as stimuli, Experimental Brain Research 92 (1992) 338-349.
75. [75] J. Sergent, S. Ohta, B. Macdonald, Functional neuroanatomy of face and object processing, Brain 115 (1992) 15-36.
76. [76] J.M. Smith, H. Misiak, Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects. A review, Psychopharmacology 47 (1976) 175-182.
77. [77] M.T. Smith, M.J. Eadie, T. O'Rourke Brophy, The pharmacokinetics of midazolam in man, European Journal of Clinical Pharmacology 19 (1981) 271-278.
78. [78] P. Soliveri, R.G. Brown, M. Jahanshahi, C.D. Marsden, Procedural memory and neurological disease, European Journal of Cognitive Psychology 4 (1992) 161-193.
79. [79] L.R. Squire, Memory and Brain, Oxford Univ. Press, New York, 1987.
80. [80] L.R. Squire, B. Knowlton, G. Musen, The structure and organization of memory, Annual Review of Psychology 44 (1993) 453-495.
81. [81] S.H. Stewart, G.F. Rioux, J.F. Connolly, S.C. Dunphy, M.D. Teehan, Effects of oxazepam and lorazepam on implicit and explicit memory: evidence for possible influences of time course, Psychopharmacology 128 (1996) 139-149.
82. [82] J.A. Swets, Signal Detection and Recognition by Human Observers, Wiley, New York, 1964.
83. [83] A. Unrug, A. Coenen, G. van Luijtelaar, Effects of the tranquillizer diazepam and the stimulant methylphenidate on alertness and memory, Neuropsychobiology 36 (1997) 42-48.
84. [84] S.E. Wolf, Modifikation der zentralnervösen Wirkung von Scopolamin durch Persönlichkeitsfaktoren [Modulation of central nervous scopolamine effects by personality traits]. Unpublished doctoral thesis. University of Giessen, Germany, 1991.
85. [85] A. Yamadori, T. Yoshida, E. Mori, H. Yamashita, Neurological basis of skill learning, Cognitive Brain Research 5 (1996) 49-54.
86. 3H]quinuclidinyl benzilate, Molecular Pharmacology 10 (1974) 861-867.
87. [87] S. Zola-Morgan, L.R. Squire, The neuroanatomy of memory, Annual Review of Neuroscience 16 (1993) 547-563.